1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Hematoma Global Clinical Trials Review, H2, 2014

Hematoma Global Clinical Trials Review, H2, 2014

  • September 2014
  • -
  • Global Data
  • -
  • 62 pages

Hematoma Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, “Hematoma Global Clinical Trials Review, H2, 2014" provides data on the Hematoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hematoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hematoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Hematoma Global Clinical Trials Review, H2, 2014
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Hematoma 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Hematoma to Cardiovascular Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Hematoma to Cardiovascular Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Hematoma 25
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Hematoma Therapeutics Clinical Trials 29
Prominent Drugs 30
Clinical Trial Profiles 31
Clinical Trial Overview of Top Companies 31
URSAPHARM Arzneimittel GmbH 31
Clinical Trial Overview of URSAPHARM Arzneimittel GmbH 31
Minapharm Pharmaceuticals and Chemical Industries 32
Clinical Trial Overview of Minapharm Pharmaceuticals and Chemical Industries 32
Baxter International Inc. 33
Clinical Trial Overview of Baxter International Inc. 33
Clinical Trial Overview of Top Institutes / Government 34
University of Ottawa Heart Institute 34
Clinical Trial Overview of University of Ottawa Heart Institute 34
Centre Hospitalier Universitaire de Saint Etienne 35
Clinical Trial Overview of Centre Hospitalier Universitaire de Saint Etienne 35
Islamic Azad University of Tabriz 36
Clinical Trial Overview of Islamic Azad University of Tabriz 36
Hvidovre University Hospital 37
Clinical Trial Overview of Hvidovre University Hospital 37
Odense University Hospital 38
Clinical Trial Overview of Odense University Hospital 38
Medical University of Vienna 39
Clinical Trial Overview of Medical University of Vienna 39
All India Institute of Medical Sciences 40
Clinical Trial Overview of All India Institute of Medical Sciences 40
Hadassah Medical Organization 41
Clinical Trial Overview of Hadassah Medical Organization 41
University Hospital, Grenoble 42
Clinical Trial Overview of University Hospital, Grenoble 42
Washington University School of Medicine 43
Clinical Trial Overview of Washington University School of Medicine 43
Five Key Clinical Profiles 44
Appendix 60
Abbreviations 60
Definitions 60
Research Methodology 61
Secondary Research 61
About GlobalData 62
Contact Us 62
Disclaimer 62
Source 62

List of Tables
Hematoma Therapeutics, Global, Clinical Trials by Region, 2014* 7
Hematoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Hematoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Hematoma Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 10
Hematoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Hematoma Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Hematoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Hematoma Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14
Proportion of Hematoma to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 15
Hematoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Hematoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Hematoma to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 18
Hematoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Hematoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Hematoma Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Hematoma Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Hematoma Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Hematoma Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Hematoma Therapeutics, Global, Terminated Clinical Trials, 2014* 25
Hematoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 26
Hematoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 27
Hematoma Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 28
Hematoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 29
Hematoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 30
Hematoma Therapeutics Clinical Trials Market, Global, Clinical Trials by URSAPHARM Arzneimittel GmbH, 2014* 31
Hematoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Minapharm Pharmaceuticals and Chemical Industries, 2014* 32
Hematoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Baxter International Inc., 2014* 33
Hematoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Ottawa Heart Institute, 2014* 34
Hematoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre Hospitalier Universitaire de Saint Etienne, 2014* 35
Hematoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Islamic Azad University of Tabriz, 2014* 36
Hematoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Hvidovre University Hospital, 2014* 37
Hematoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Odense University Hospital, 2014* 38
Hematoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2014* 39
Hematoma Therapeutics Clinical Trials Market, Global, Clinical Trials by All India Institute of Medical Sciences, 2014* 40
Hematoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Hadassah Medical Organization, 2014* 41
Hematoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital, Grenoble, 2014* 42
Hematoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Washington University School of Medicine, 2014* 43

List of Figures
Hematoma Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Hematoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Hematoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Hematoma Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 10
Hematoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Hematoma Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Hematoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 13
Proportion of Hematoma to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 15
Hematoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Hematoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Hematoma to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 18
Hematoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Hematoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Hematoma Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Hematoma Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Hematoma Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Hematoma Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Hematoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 26
Hematoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 27
Hematoma Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 28
Hematoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 29
Hematoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 30
GlobalData Methodology 61

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.